Half-year report · HY
7716.TEDINET S100YULE
Period2026-01-01 → 2026-06-30
Filed2026-08-07
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥47.2bn | 2026-01-01 → 2026-06-30 | Cons. | Net sales |
| Revenue | ¥81.2bn | 2025-01-01 → 2025-12-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥39.2bn | 2025-01-01 → 2025-06-30 | Cons. | Net sales |
| Operating income | ¥10.0bn | 2026-01-01 → 2026-06-30 | Cons. | Operating income |
| Operating income | ¥7.6bn | 2025-01-01 → 2025-06-30 | Cons. | Operating income |
| Ordinary income | ¥11.6bn | 2026-01-01 → 2026-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥16.9bn | 2025-01-01 → 2025-12-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥6.9bn | 2025-01-01 → 2025-06-30 | Cons. | Ordinary income |
| Profit before tax | ¥11.5bn | 2026-01-01 → 2026-06-30 | Cons. | Income before income taxes |
| Profit before tax | ¥7.0bn | 2025-01-01 → 2025-06-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥8.1bn | 2026-01-01 → 2026-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥2.4bn | 2025-01-01 → 2025-12-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥3.5bn | 2025-01-01 → 2025-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥8.1bn | 2026-01-01 → 2026-06-30 | Cons. | Profit loss |
| Net income | ¥3.5bn | 2025-01-01 → 2025-06-30 | Cons. | Profit loss |
| Total assets | ¥174.6bn | at 2026-06-30 | Cons. | Assets |
| Total assets | ¥160.2bn | at 2025-12-31 | Cons. | Assets |
| Total assets | ¥153.8bn | at 2025-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥52.5bn | at 2026-06-30 | Cons. | Liabilities |
| Total liabilities | ¥46.1bn | at 2025-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥122.0bn | at 2026-06-30 | Cons. | Net assets |
| Net assets / equity | ¥114.1bn | at 2025-12-31 | Cons. | Net assets |
| Net assets / equity | ¥117.3bn | at 2025-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥56.4bn | at 2026-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥61.3bn | at 2025-12-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥40.4bn | at 2026-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥46.0bn | at 2025-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥32.7bn | at 2025-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥35.2bn | at 2024-12-31v | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥7.6bn | 2026-01-01 → 2026-06-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥16.6bn | 2025-01-01 → 2025-12-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥7.6bn | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥19.0bn | 2026-01-01 → 2026-06-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥8.7bn | 2025-01-01 → 2025-12-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥6.4bn | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥4.7bn | 2026-01-01 → 2026-06-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥679m | 2025-01-01 → 2025-12-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥2.6bn | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥98.07 | 2026-01-01 → 2026-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-28.7 | 2025-01-01 → 2025-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥41.84 | 2025-01-01 → 2025-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥97.72 | 2026-01-01 → 2026-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥41.7 | 2025-01-01 → 2025-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 69.6% | at 2026-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 71.0% | at 2025-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 76.0% | at 2025-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 40
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2026-01-01 → 2026-06-30 | −¥443m |
| Reconciling Itemsreconciling | revenue intersegment | 2026-01-01 → 2026-06-30 | −¥443m |
| Reconciling Itemsreconciling | segment profit | 2026-01-01 → 2026-06-30 | −¥2.2bn |
| DCI Productsreportable segment | revenue | 2026-01-01 → 2026-06-30 | ¥12.2bn |
| DCI Productsreportable segment | revenue external | 2026-01-01 → 2026-06-30 | ¥12.2bn |
| DCI Productsreportable segment | segment profit | 2026-01-01 → 2026-06-30 | ¥674m |
| Dental Productsreportable segment | revenue | 2026-01-01 → 2026-06-30 | ¥27.4bn |
| Dental Productsreportable segment | revenue external | 2026-01-01 → 2026-06-30 | ¥27.0bn |
| Dental Productsreportable segment | revenue intersegment | 2026-01-01 → 2026-06-30 | ¥443m |
| Dental Productsreportable segment | segment profit | 2026-01-01 → 2026-06-30 | ¥9.0bn |
| Industrial Productsreportable segment | revenue | 2026-01-01 → 2026-06-30 | ¥4.2bn |
| Industrial Productsreportable segment | revenue external | 2026-01-01 → 2026-06-30 | ¥4.2bn |
| Industrial Productsreportable segment | segment profit | 2026-01-01 → 2026-06-30 | ¥1.1bn |
| Surgical Productsreportable segment | revenue | 2026-01-01 → 2026-06-30 | ¥3.9bn |
| Surgical Productsreportable segment | revenue external | 2026-01-01 → 2026-06-30 | ¥3.9bn |
| Surgical Productsreportable segment | segment profit | 2026-01-01 → 2026-06-30 | ¥1.5bn |
| —segment total | revenue | 2026-01-01 → 2026-06-30 | ¥47.7bn |
| —segment total | revenue external | 2026-01-01 → 2026-06-30 | ¥47.2bn |
| —segment total | revenue intersegment | 2026-01-01 → 2026-06-30 | ¥443m |
| —segment total | segment profit | 2026-01-01 → 2026-06-30 | ¥12.3bn |
| Reconciling Itemsreconciling | revenue | 2025-01-01 → 2025-06-30 | −¥176m |
| Reconciling Itemsreconciling | revenue intersegment | 2025-01-01 → 2025-06-30 | −¥176m |
| Reconciling Itemsreconciling | segment profit | 2025-01-01 → 2025-06-30 | −¥2.0bn |
| DCI Productsreportable segment | revenue | 2025-01-01 → 2025-06-30 | ¥9.8bn |
| DCI Productsreportable segment | revenue external | 2025-01-01 → 2025-06-30 | ¥9.8bn |
| DCI Productsreportable segment | segment profit | 2025-01-01 → 2025-06-30 | ¥66m |
| Dental Productsreportable segment | revenue | 2025-01-01 → 2025-06-30 | ¥23.7bn |
| Dental Productsreportable segment | revenue external | 2025-01-01 → 2025-06-30 | ¥23.5bn |
| Dental Productsreportable segment | revenue intersegment | 2025-01-01 → 2025-06-30 | ¥176m |
| Dental Productsreportable segment | segment profit | 2025-01-01 → 2025-06-30 | ¥8.0bn |
| Industrial Productsreportable segment | revenue | 2025-01-01 → 2025-06-30 | ¥3.3bn |
| Industrial Productsreportable segment | revenue external | 2025-01-01 → 2025-06-30 | ¥3.3bn |
| Industrial Productsreportable segment | segment profit | 2025-01-01 → 2025-06-30 | ¥306m |
| Surgical Productsreportable segment | revenue | 2025-01-01 → 2025-06-30 | ¥2.5bn |
| Surgical Productsreportable segment | revenue external | 2025-01-01 → 2025-06-30 | ¥2.5bn |
| Surgical Productsreportable segment | segment profit | 2025-01-01 → 2025-06-30 | ¥1.2bn |
| —segment total | revenue | 2025-01-01 → 2025-06-30 | ¥39.4bn |
| —segment total | revenue external | 2025-01-01 → 2025-06-30 | ¥39.2bn |
| —segment total | revenue intersegment | 2025-01-01 → 2025-06-30 | ¥176m |
| —segment total | segment profit | 2025-01-01 → 2025-06-30 | ¥9.6bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 542
| Item | Context | Value | Unit |
|---|---|---|---|
| Net assets | Prior1YearInstant | 114074441000 | JPY |
| Net assets | InterimInstant | 122009771000 | JPY |
| Liabilities and net assets | Prior1YearInstant | 160155463000 | JPY |
| Liabilities and net assets | InterimInstant | 174551385000 | JPY |
| Net sales | Prior1InterimDuration | 39189728000 | JPY |
| Net sales | InterimDuration | 47234964000 | JPY |
| Cost of sales | Prior1InterimDuration | 16085555000 | JPY |
| Cost of sales | InterimDuration | 19810058000 | JPY |
| Gross profit | Prior1InterimDuration | 23104173000 | JPY |
| Gross profit | InterimDuration | 27424905000 | JPY |
| Selling general and administrative expenses | Prior1InterimDuration | 15516951000 | JPY |
| Selling general and administrative expenses | InterimDuration | 17412393000 | JPY |
| Operating income | Prior1InterimDuration | 7587221000 | JPY |
| Operating income | InterimDuration | 10012512000 | JPY |
| Interest income noi | Prior1InterimDuration | 410079000 | JPY |
| Interest income noi | InterimDuration | 484594000 | JPY |
| Dividends income noi | Prior1InterimDuration | 45985000 | JPY |
| Dividends income noi | InterimDuration | 61468000 | JPY |
| Subsidy income noi | Prior1InterimDuration | 10000000 | JPY |
| Subsidy income noi | InterimDuration | 10000000 | JPY |
| Foreign exchange gains noi | Prior1InterimDuration | - | JPY |
| Foreign exchange gains noi | InterimDuration | 1130753000 | JPY |
| Miscellaneous income noi | Prior1InterimDuration | 137437000 | JPY |
| Miscellaneous income noi | InterimDuration | 190356000 | JPY |
| Non operating income | Prior1InterimDuration | 603502000 | JPY |
| Non operating income | InterimDuration | 1877173000 | JPY |
| Interest expenses noe | Prior1InterimDuration | 75828000 | JPY |
| Interest expenses noe | InterimDuration | 189964000 | JPY |
| Commission fee noe | Prior1InterimDuration | 2097000 | JPY |
| Commission fee noe | InterimDuration | - | JPY |
| Foreign exchange losses noe | Prior1InterimDuration | 1168669000 | JPY |
| Foreign exchange losses noe | InterimDuration | - | JPY |
| Miscellaneous loss noe | Prior1InterimDuration | 13805000 | JPY |
| Miscellaneous loss noe | InterimDuration | 122401000 | JPY |
| Non operating expenses | Prior1InterimDuration | 1260400000 | JPY |
| Non operating expenses | InterimDuration | 312366000 | JPY |
| Ordinary income | Prior1InterimDuration | 6930322000 | JPY |
| Ordinary income | InterimDuration | 11577319000 | JPY |
| Gain on sales of noncurrent assets ei | Prior1InterimDuration | 1061000 | JPY |
| Gain on sales of noncurrent assets ei | InterimDuration | 0 | JPY |
| Reversal of provision for loss on litigation ei | Prior1InterimDuration | 164920000 | JPY |
| Reversal of provision for loss on litigation ei | InterimDuration | - | JPY |
| Extraordinary income | Prior1InterimDuration | 165981000 | JPY |
| Extraordinary income | InterimDuration | 0 | JPY |
| Loss on sales of noncurrent assets el | Prior1InterimDuration | - | JPY |
| Loss on sales of noncurrent assets el | InterimDuration | 28000 | JPY |
| Loss on retirement of noncurrent assets el | Prior1InterimDuration | 22785000 | JPY |
| Loss on retirement of noncurrent assets el | InterimDuration | 56215000 | JPY |
| Impairment loss el | Prior1InterimDuration | 8053000 | JPY |
| Impairment loss el | InterimDuration | - | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |